DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer

[1]  Arnoldo Frigessi,et al.  Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis , 2014, Genome Biology.

[2]  G. Montgomery,et al.  Genome‐wide DNA methylation analysis of formalin‐fixed paraffin embedded colorectal cancer tissue , 2014, Genes, chromosomes & cancer.

[3]  M. Esteller,et al.  Validation of DNA methylation profiling in formalin-fixed paraffin-embedded samples using the Infinium HumanMethylation450 Microarray , 2014, Epigenetics.

[4]  Nancy L Keating,et al.  A systematic assessment of benefits and risks to guide breast cancer screening decisions. , 2014, JAMA.

[5]  E. Marshall.  Breast cancer. Dare to do less. , 2014, Science.

[6]  Andrew E. Teschendorff,et al.  ChAMP: 450k Chip Analysis Methylation Pipeline , 2014, Bioinform..

[7]  L. Graves,et al.  Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function , 2013, Oncogene.

[8]  T. Julian,et al.  Ductal carcinoma in situ: a rose by any other name. , 2013, Journal of the National Cancer Institute.

[9]  P. Lønning,et al.  Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors , 2013, BMC Cancer.

[10]  Manel Esteller,et al.  Epigenetic modifications in breast cancer and their role in personalized medicine. , 2013, The American journal of pathology.

[11]  Howard Y. Chang,et al.  HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERα and inducing IL-6 expression. , 2013, Cancer research.

[12]  S. Fox,et al.  DNA methylation in ductal carcinoma in situ of the breast , 2013, Breast Cancer Research.

[13]  T. Julian,et al.  A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ. , 2013, Journal of the National Cancer Institute.

[14]  A E Giuliano,et al.  Assessment of DNA methylation status in early stages of breast cancer development , 2013, British Journal of Cancer.

[15]  Sivan Sabato,et al.  DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes , 2013, Genome Biology.

[16]  Tim Fenton,et al.  Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma , 2013, Genome Medicine.

[17]  Francesco Marabita,et al.  A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data , 2012, Bioinform..

[18]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[19]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[20]  O. Ammerpohl,et al.  Quantitative cross-validation and content analysis of the 450k DNA methylation array from Illumina, Inc. , 2012, BMC Research Notes.

[21]  T. H. van der Kwast,et al.  Correlation of ERG Expression and DNA Methylation Biomarkers with Adverse Clinicopathologic Features of Prostate Cancer , 2012, Clinical Cancer Research.

[22]  C. Eng,et al.  GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer. , 2012, Human molecular genetics.

[23]  C. Sotiriou,et al.  Evaluation of the Infinium Methylation 450K technology. , 2011, Epigenomics.

[24]  Peng Huang,et al.  Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. , 2011, Cancer research.

[25]  P. V. van Diest,et al.  Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer , 2011, The Journal of pathology.

[26]  David Haussler,et al.  Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling , 2011, Proceedings of the National Academy of Sciences.

[27]  Fang Fang,et al.  Breast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis , 2011, Science Translational Medicine.

[28]  Kornelia Polyak,et al.  Molecular markers for the diagnosis and management of ductal carcinoma in situ. , 2010, Journal of the National Cancer Institute. Monographs.

[29]  B. Christensen,et al.  Identification of Methylated Genes Associated with Aggressive Bladder Cancer , 2010, PloS one.

[30]  B. Christensen,et al.  Breast Cancer DNA Methylation Profiles Are Associated with Tumor Size and Alcohol and Folate Intake , 2010, PLoS genetics.

[31]  Saraswati Sukumar,et al.  The Hox genes and their roles in oncogenesis , 2010, Nature Reviews Cancer.

[32]  Matthew D. Wilkerson,et al.  ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..

[33]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[34]  M. Esteller,et al.  Breast Cancer Epigenetics: From DNA Methylation to microRNAs , 2010, Journal of Mammary Gland Biology and Neoplasia.

[35]  T. Sørlie,et al.  Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer , 2010, Breast Cancer Research.

[36]  Yun Yen,et al.  Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer , 2009, Breast Cancer Research.

[37]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[38]  C. Shapiro,et al.  Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer. , 2008, Carcinogenesis.

[39]  P. Carney,et al.  Breast density in relation to risk of ductal carcinoma in situ of the breast in women undergoing screening mammography , 2007, Cancer Causes & Control.

[40]  T Takahashi,et al.  Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach , 2007, Oncogene.

[41]  Zohar Yakhini,et al.  Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer , 2007, Nature Genetics.

[42]  J. Peterse,et al.  Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Henriette O'Geen,et al.  Suz12 binds to silenced regions of the genome in a cell-type-specific manner. , 2006, Genome research.

[44]  Kristian Helin,et al.  Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. , 2006, Genes & development.

[45]  J. Jones,et al.  Overdiagnosis and overtreatment of breast cancer: Progression of ductal carcinoma in situ: the pathological perspective , 2006, Breast Cancer Research.

[46]  Megan F. Cole,et al.  Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.

[47]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[48]  C. Key,et al.  The frequency of ipsilateral second tumors after breast‐conserving surgery for DCIS , 2005, Cancer.

[49]  V Shane Pankratz,et al.  Benign breast disease and the risk of breast cancer. , 2005, The New England journal of medicine.

[50]  Jill P. Mesirov,et al.  Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray Data , 2003, Machine Learning.

[51]  Martin Widschwendter,et al.  DNA methylation and breast carcinogenesis , 2002, Oncogene.

[52]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[53]  C. Marsit,et al.  Distinct patterns of DNA methylation in conventional adenomas involving the right and left colon , 2014, Modern Pathology.

[54]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[55]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[56]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[57]  H. Iwase,et al.  [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[58]  Terrence S. Furey,et al.  The UCSC Table Browser data retrieval tool , 2004, Nucleic Acids Res..

[59]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.